Molecular Pathology and Therapy of Endometriosis: Revisited

In: Andrology & Gynecology: Current Research · 2013 · vol. 01(03) · doi:10.4172/2327-4360.1000105 · W2323351786
article OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This review revisits the molecular pathology and therapy of endometriosis, highlighting the complex, multifactorial nature of the disease and the ongoing challenges in understanding its etiopathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-06 · read from full text

This article is a narrative review revisiting molecular pathology and therapeutic considerations in endometriosis, focusing on what is known about its etiopathogenesis in women of reproductive age. It describes endometriosis as a complex, hormone-dependent, multifactorial condition involving interactions among genetic, immunological, hormonal, and environmental factors. The authors report that while molecular mechanisms have been investigated intensely over the past decade, the overall causes and pathogenesis remain incompletely understood, a caveat supported by the scarcity of clear mechanistic understanding and by setbacks in clinical trials. This paper is centrally about endometriosis — it revisits the molecular pathways implicated in endometriosis and how those mechanisms relate to therapy.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Molecular Pathology and Therapy of Endometriosis: Revisited Endometriosis is among one of the most challenging diseases of the 21st century that affects women in their reproductive age, and its aetiology and pathogenesis remains enigmatic. Unravelling the molecular mechanisms that play a role in the etiopathogenesis of endometriosis has been the subject of intense investigation over the last decade. It is a complex hormone dependent and multifactorial disease involving intricate communications of genetic, immunological, hormonal and environmental factors and the clear understanding of the etiopathogenesis of endometriosis is scarce, as indicated by many studies and recent setbacks in clinical trials.
Full text 1,791 characters · extracted from oa-doi-fallback · click to expand
Review Article, Androl Gynecol Curr Res Vol: 1 Issue: 3 Molecular Pathology and Therapy of Endometriosis: Revisited | Padmanaban S Suresh1*, Thejaswini Venkatesh2, Thangarasu Rajan3 and Rie Tsutsumi4 | | | 1Centre for Biomedical Research, Vellore Institute of Technology (VIT), Tamilnadu, India | | | 2Dept of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India | | | 3Aarupadai Veedu Medical College and Hospital, Puducherry, India | | | 4University of Tokushima, Institute of Health Bioscience, Department of Public health and nutrition, Japan | | | Corresponding author : Suresh PS, PhD Centre for Biomedical Research, Vellore Institute of Technology, VIT University, Vellore - 632 014, Tamilnadu, India Tel: 91-9597872269; E-mail: [email protected] | | | Received: April 05, 2013 Accepted: May 17, 2013 Published: May 22, 2013 | | | Citation: Suresh PS, Venkatesh T, Rajan T, Tsutsumi R (2013) Molecular Pathology and Therapy of Endometriosis: Revisited. Androl Gynecol: Curr Res 1:3. doi:10.4172/2327-4360.1000105 | Abstract Molecular Pathology and Therapy of Endometriosis: Revisited Endometriosis is among one of the most challenging diseases of the 21st century that affects women in their reproductive age, and its aetiology and pathogenesis remains enigmatic. Unravelling the molecular mechanisms that play a role in the etiopathogenesis of endometriosis has been the subject of intense investigation over the last decade. It is a complex hormone dependent and multifactorial disease involving intricate communications of genetic, immunological, hormonal and environmental factors and the clear understanding of the etiopathogenesis of endometriosis is scarce, as indicated by many studies and recent setbacks in clinical trials.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (88)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK